Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab”

432 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 432 results

Post-approval studies (Phase 4)Study completedNCT03301883
What this trial is testing

Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 62
Not applicableStudy completedNCT02419937
What this trial is testing

Short-Term Application of Tocilizumab Following Myocardial Infarction

Who this might be right for
Myocardial Infarction
Keesler Air Force Base Medical Center 28
Not applicableEnded earlyNCT01643863
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1
Large-scale testing (Phase 3)Study completedNCT00810199
What this trial is testing

Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 556
Testing effectiveness (Phase 2)Ended earlyNCT04335305
What this trial is testing

Checkpoint Blockade in COVID-19 Pandemic

Who this might be right for
COVID-19Pneumonia, Viral
MedSIR 12
Testing effectiveness (Phase 2)Study completedNCT04331795
What this trial is testing

Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis

Who this might be right for
COVID-19
University of Chicago 32
Early research (Phase 1)Ended earlyNCT04070781
What this trial is testing

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory GVHDGraft Vs Host Disease
Columbia University 1
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Testing effectiveness (Phase 2)Study completedNCT02767557
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Who this might be right for
Unresectable Pancreatic Carcinoma
Herlev Hospital 147
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04888221
What this trial is testing

Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement

Who this might be right for
Giant Cell ArteritisNeurovascular Disorder
Assistance Publique - Hôpitaux de Paris 66
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Large-scale testing (Phase 3)Study completedNCT01353859
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 39
Not applicableStudy completedNCT07459335
What this trial is testing

TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients

Who this might be right for
Giant Cell Arteritis (GCA)Cardiovascular Diseases
Groupe français d'étude des Maladies Inflammatoires de loeil 1,667
Not applicableNo Longer AvailableNCT00862758
What this trial is testing

Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

Who this might be right for
Juvenile Idiopathic Arthritis
University of Oklahoma
Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Not applicableWithdrawnNCT04850443
What this trial is testing

Treatment of IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

Who this might be right for
Critical Illness Sepsis, Severe
Children's Hospital of Fudan University
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Next Page